Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...
Our aim is to enhance the delivery of precision medicine by assembling and supporting UAB researchers and clinicians in an interdisciplinary program aimed at discovering and applying new knowledge.